制药ETF投资于参与研究，开发，制造，销售或分销所有类型的药品和药物的公司股票
* 资产及平均交易量 截至 2022-06-23 16：18 EDT
| Symbol | ETF Name | Sector | Total Assets ($MM) | YTD | Avg Volume | Previous Closing Price | 1-Day Change | Overall Rating |
|---|---|---|---|---|---|---|---|---|
| PPH | VanEck Pharmaceutical ETF | Healthcare | $505.07 | -0.59% | 175,491 | $76.08 | 1.36% | A- |
| IHE | iShares U.S. Pharmaceuticals ETF | Healthcare | $408.53 | -4.00% | 13,936 | $190.16 | 2.43% | C+ |
| PJP | Invesco Dynamic Pharmaceuticals ETF | Healthcare | $297.32 | -7.97% | 16,106 | $74.26 | 2.90% | B |
| XPH | SPDR S&P Pharmaceuticals ETF | Healthcare | $183.42 | -8.90% | 63,845 | $41.70 | 3.45% | B |
| KURE | KraneShares MSCI All China Health Care Index ETF | Healthcare | $118.40 | -22.30% | 23,106 | $22.30 | 1.13% | N/A |
| POTX | Global X Cannabis ETF | Healthcare | $50.48 | -49.39% | 32,210 | $17.67 | 2.43% | N/A |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | Healthcare | $29.77 | -1.56% | 12,668 | $26.59 | 2.78% | N/A |
| PILL | Direxion Daily Pharmaceutical & Medical Bull 3X Shares | Healthcare | $12.49 | -33.26% | 35,880 | $10.59 | 9.97% | N/A |
| CHIH | Global X MSCI China Health Care ETF | Healthcare | $11.74 | -23.42% | 4,581 | $16.59 | 1.10% | N/A |
| CHNA | Loncar China BioPharma ETF | Healthcare | $5.79 | -26.43% | 4,052 | $19.68 | 1.65% | A- |
| CHB | Global X China Biotech Innovation ETF | Healthcare | $2.86 | -25.09% | 932 | $10.60 | 0.47% | N/A |
| PSYK | PSYK ETF | Healthcare | $1.07 | N/A | 766 | $18.53 | 3.29% | N/A |
制药行业实力排名
| 3个月资金流量： | $148 M | 21st |
| 平均 3 个月回报率： | -10.57% | 15th |
| 合计资产管理规模： | $1,555 M | 41st |
| 平均费用比率： | 0.45% | 28 th |
| 平均股息收益率： | 1.15% | 39 th |